As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pfizer: Hudson Bay Capital Management LP, Nomura Holdings Inc., National Bank of Canada FI, Man Group plc, LMR Partners LLP, Hudson Bay Capital Management LP, Group One Trading LLC, BNP Paribas Financial Markets, Balyasny Asset Management L.P., Bank of America Corp DE, Jane Street Group LLC, Volterra Technologies LP, Squarepoint Ops LLC, Alphadyne Asset Management LP, Qube Research & Technologies Ltd, Maven Securities LTD, Bank of Nova Scotia, Capital Markets Trading UK LLP, CMT Capital Markets Trading GmbH, Capula Management Ltd, Walleye Capital LLC, Walleye Trading LLC, Groupe la Francaise, Capital Fund Management S.A., Jefferies Financial Group Inc., Eisler Capital Management Ltd., JPMorgan Chase & Co., Wernau Asset Management Inc., Citigroup Inc., SG Americas Securities LLC, Garda Capital Partners LP, Marathon Trading Investment Management LLC, Credit Industriel ET Commercial, Mirae Asset Securities USA Inc., Wolverine Asset Management LLC, Allianz Asset Management GmbH, Twin Tree Management LP, Credit Industriel ET Commercial, Total Wealth Planning & Management Inc., DAVENPORT & Co LLC, IMC Chicago LLC, and Quaker Wealth Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.